Metabolic therapies inhibit tumor growth in vivo and in silico

In the recent years, cancer research succeeded with sensitive detection methods, targeted drug delivery systems, and the identification of a large set of genes differently expressed. However, although most therapies are still based on antimitotic agents, which are causing wide secondary effects, the...

Descripción completa

Detalles Bibliográficos
Autores principales: da Veiga Moreira, Jorgelindo, Hamraz, Minoo, Abolhassani, Mohammad, Schwartz, Laurent, Jolicœur, Mario, Peres, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395653/
https://www.ncbi.nlm.nih.gov/pubmed/30816152
http://dx.doi.org/10.1038/s41598-019-39109-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395653/
https://www.ncbi.nlm.nih.gov/pubmed/30816152
http://dx.doi.org/10.1038/s41598-019-39109-1

Ejemplares similares